1. Home
  2. APLM vs MI Comparison

APLM vs MI Comparison

Compare APLM & MI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLM
  • MI
  • Stock Information
  • Founded
  • APLM 2016
  • MI 2009
  • Country
  • APLM United States
  • MI Hong Kong
  • Employees
  • APLM N/A
  • MI N/A
  • Industry
  • APLM Blank Checks
  • MI Catalog/Specialty Distribution
  • Sector
  • APLM Finance
  • MI Consumer Discretionary
  • Exchange
  • APLM Nasdaq
  • MI Nasdaq
  • Market Cap
  • APLM 15.6M
  • MI 13.0M
  • IPO Year
  • APLM N/A
  • MI N/A
  • Fundamental
  • Price
  • APLM $0.14
  • MI $8.71
  • Analyst Decision
  • APLM Strong Buy
  • MI
  • Analyst Count
  • APLM 2
  • MI 0
  • Target Price
  • APLM $4.25
  • MI N/A
  • AVG Volume (30 Days)
  • APLM 892.5K
  • MI 16.9K
  • Earning Date
  • APLM 08-14-2024
  • MI 01-01-0001
  • Dividend Yield
  • APLM N/A
  • MI N/A
  • EPS Growth
  • APLM N/A
  • MI N/A
  • EPS
  • APLM N/A
  • MI 1.16
  • Revenue
  • APLM $2,101,000.00
  • MI $1,273,946.00
  • Revenue This Year
  • APLM N/A
  • MI N/A
  • Revenue Next Year
  • APLM N/A
  • MI N/A
  • P/E Ratio
  • APLM N/A
  • MI $7.43
  • Revenue Growth
  • APLM 70.54
  • MI N/A
  • 52 Week Low
  • APLM $0.11
  • MI $3.08
  • 52 Week High
  • APLM $2.60
  • MI $16.70
  • Technical
  • Relative Strength Index (RSI)
  • APLM 49.47
  • MI 74.49
  • Support Level
  • APLM $0.13
  • MI $7.50
  • Resistance Level
  • APLM $0.17
  • MI $8.50
  • Average True Range (ATR)
  • APLM 0.01
  • MI 0.75
  • MACD
  • APLM 0.00
  • MI 0.03
  • Stochastic Oscillator
  • APLM 37.93
  • MI 78.62

About APLM Apollomics Inc.

Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

About MI NFT Limited

NFT Ltd Formerly Takung Art Co Ltd operates an online electronic platform for offering and trading artwork. Through its platform, the company allows artists/art dealers/owners to access a much bigger art trading market where artists can engage with a wide range of investors. Its platform also invests in high-end artwork accessible to ordinary people without financial resources. The company's trading platforms comprise the sale of calligraphies and paintings, jewelry, and precious stones. It generates revenue in the form of services in connection with the offering and trading of artwork on its system, consisting of listing fees, trading commissions, and management fees.

Share on Social Networks: